ABL

Abbott Laboratories · SWB:ABL

98.30 EUR−0.1000 −0.10%

Abbott Laboratories (SWB:ABL) last traded at 98.30 EUR, down 0.10% on the day. Over the past year the stock is down 8.03%. Its 52-week range is 69.64 to 112.30. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open98.14

Day range97.18 – 98.54

52-week range69.64 – 112.30

Volume0

Average volume (10 days)182

Market cap (USD)190.62 B

P/E41.11

EPS (TTM) (USD)2.71

Dividend yield2.29%

Beta (1 year)0.3618

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+5.04%1 week

+14.86%1 month

+7.57%3 months

+33.92%6 months

−7.60%Year to date

−8.03%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Abbott Touts Favorable Outcomes In Cardiovascular Device TrialsBenzinga · 02 Nov 2026
Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.